Compare TFII & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFII | CRL |
|---|---|---|
| Founded | 1957 | 1947 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | TFII | CRL |
|---|---|---|
| Price | $115.44 | $158.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $121.09 | ★ $205.27 |
| AVG Volume (30 Days) | 411.8K | ★ 759.8K |
| Earning Date | 02-17-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $8,047,566,000.00 | $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.77 | $1.70 |
| P/E Ratio | $32.29 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $72.02 | $91.86 |
| 52 Week High | $131.33 | $228.88 |
| Indicator | TFII | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 22.25 |
| Support Level | $118.46 | $181.77 |
| Resistance Level | $122.88 | $218.69 |
| Average True Range (ATR) | 4.42 | 9.44 |
| MACD | 0.39 | -6.36 |
| Stochastic Oscillator | 41.95 | 13.76 |
TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.